Authors:
Feliu, J
Martin, G
Lizon, J
Chacon, JI
Dorta, J
de Castro, J
Rodriguez, A
Heras, BS
Torrego, JC
Espinosa, E
Baron, MG
Citation: J. Feliu et al., Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study, ANN ONCOL, 12(10), 2001, pp. 1369-1374
Authors:
Uzcudun, AE
Fernandez, PB
Sanchez, JJ
Grande, AG
Retolaza, IR
Baron, MG
Bouzas, JG
Citation: Ae. Uzcudun et al., Clinical features of pharyngeal cancer: a retrospective study of 258 consecutive patients, J LARYNG OT, 115(2), 2001, pp. 112-118
Authors:
Feliu, J
Alvarez, MPL
Jaraiz, MA
Constenla, M
Vicent, JM
Belon, J
Gomez, LL
de Castro, J
Dorta, J
Baron, MG
Citation: J. Feliu et al., Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma, CANCER, 89(8), 2000, pp. 1706-1713
Citation: Gk. Schwartz et al., Raltitrexed (Tomudex (TM)) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: Preliminary results fromphase I clinical trials, EUR J CANC, 35, 1999, pp. S9-S13
Authors:
Feliu, J
Gomez, LL
Madronal, C
Espinosa, E
Espinosa, J
Giron, CG
Martinez, B
Castro, J
De la Gandara, I
Baron, MG
Citation: J. Feliu et al., Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin, CANCER, 86(8), 1999, pp. 1463-1469